These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36088492)

  • 1. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism.
    Martínez-Torres S; Bergadà-Martínez A; Ortega JE; Galera-López L; Hervera A; de Los Reyes-Ramírez L; Ortega-Álvaro A; Remmers F; Muñoz-Moreno E; Soria G; Del Río JA; Lutz B; Ruíz-Ortega JÁ; Meana JJ; Maldonado R; Ozaita A
    Neuropsychopharmacology; 2023 Jan; 48(2):341-350. PubMed ID: 36088492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
    Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
    Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus.
    Zhang J; Wang N; Chen B; Wang Y; He J; Cai X; Zhang H; Wei S; Li S
    Neurosci Lett; 2016 Sep; 630():70-76. PubMed ID: 27461790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity.
    Boon MR; Kooijman S; van Dam AD; Pelgrom LR; Berbée JF; Visseren CA; van Aggele RC; van den Hoek AM; Sips HC; Lombès M; Havekes LM; Tamsma JT; Guigas B; Meijer OC; Jukema JW; Rensen PC
    FASEB J; 2014 Dec; 28(12):5361-75. PubMed ID: 25154875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action.
    Degroot A; Köfalvi A; Wade MR; Davis RJ; Rodrigues RJ; Rebola N; Cunha RA; Nomikos GG
    Mol Pharmacol; 2006 Oct; 70(4):1236-45. PubMed ID: 16855179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation.
    Busquets-Garcia A; Gomis-González M; Srivastava RK; Cutando L; Ortega-Alvaro A; Ruehle S; Remmers F; Bindila L; Bellocchio L; Marsicano G; Lutz B; Maldonado R; Ozaita A
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9904-9. PubMed ID: 27528659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits.
    Subbanna S; Shivakumar M; Psychoyos D; Xie S; Basavarajappa BS
    J Neurosci; 2013 Apr; 33(15):6350-66. PubMed ID: 23575834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome.
    Navarro-Romero A; Vázquez-Oliver A; Gomis-González M; Garzón-Montesinos C; Falcón-Moya R; Pastor A; Martín-García E; Pizarro N; Busquets-Garcia A; Revest JM; Piazza PV; Bosch F; Dierssen M; de la Torre R; Rodríguez-Moreno A; Maldonado R; Ozaita A
    Neurobiol Dis; 2019 May; 125():92-106. PubMed ID: 30685352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents.
    Cluny NL; Vemuri VK; Chambers AP; Limebeer CL; Bedard H; Wood JT; Lutz B; Zimmer A; Parker LA; Makriyannis A; Sharkey KA
    Br J Pharmacol; 2010 Oct; 161(3):629-42. PubMed ID: 20880401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of primary sensory neurone cannabinoid type-1 receptors in pain and the analgesic effects of the peripherally acting agonist CB-13 in mice.
    Ford NC; Barpujari A; He SQ; Huang Q; Zhang C; Dong X; Guan Y; Raja SN
    Br J Anaesth; 2022 Jan; 128(1):159-173. PubMed ID: 34844727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential inhibitory plasticities in hippocampal area CA2 and social memory formation.
    Loisy M; Bouisset G; Lopez S; Muller M; Spitsyn A; Duval J; Piskorowski RA; Verret L; Chevaleyre V
    Neuron; 2022 Sep; 110(17):2854-2866.e4. PubMed ID: 35858622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus-norepinephrine neurons and corticotropin releasing factor-mediated responses.
    Wyrofsky RR; Reyes BAS; Yu D; Kirby LG; Van Bockstaele EJ
    Eur J Neurosci; 2018 Sep; 48(5):2118-2138. PubMed ID: 30103253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus.
    Iglesias LP; Fernandes HB; de Miranda AS; Perez MM; Faccioli LH; Sorgi CA; Bertoglio LJ; Aguiar DC; Wotjak CT; Moreira FA
    Neuropharmacology; 2023 Feb; 224():109314. PubMed ID: 36336070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens.
    Ahmad T; Sun N; Lyons D; Laviolette SR
    Addict Biol; 2017 Sep; 22(5):1218-1231. PubMed ID: 27230434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice.
    Subbanna S; Nagre NN; Umapathy NS; Pace BS; Basavarajappa BS
    Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25609594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.
    Han JH; Shin H; Park JY; Rho JG; Son DH; Kim KW; Seong JK; Yoon SH; Kim W
    FASEB J; 2019 Mar; 33(3):4314-4326. PubMed ID: 30566396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning.
    Nasehi M; Zamanparvar M; Ebrahimi-Ghiri M; Zarrindast MR
    Behav Brain Res; 2016 Mar; 300():114-22. PubMed ID: 26698395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice.
    Ma H; Zhang G; Mou C; Fu X; Chen Y
    Front Pharmacol; 2018; 9():156. PubMed ID: 29615900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB
    Saravia R; Flores Á; Plaza-Zabala A; Busquets-Garcia A; Pastor A; de la Torre R; Di Marzo V; Marsicano G; Ozaita A; Maldonado R; Berrendero F
    Biol Psychiatry; 2017 Apr; 81(7):625-634. PubMed ID: 27737762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cannabinoid signaling by hippocampal 5-HT4 serotonergic system in fear conditioning.
    Nasehi M; Farrahizadeh M; Ebrahimi-Ghiri M; Zarrindast MR
    J Psychopharmacol; 2016 Sep; 30(9):936-44. PubMed ID: 27296273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.